189 results
Page 2 of 10
6-K
EX-99.2
kqxx82l8izzk
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.2
ccxjya7hsp3i9vu5nzj
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.1
6ni3mf 7ocqiufr25h7w
25 Oct 22
Current report (foreign)
12:27pm
20-F/A
nzb rvah4i
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
9x8xdaf z9r
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.2
snab43
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
cbw3t6ex
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
qua7a ml1n8snf81
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.3
fgvrd
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
b1dv7
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
3y1al96jzemegvk786
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
dgarpgj
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.1
p4o mpdnrz3z0ct2nf9
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
wla8ji xrim16
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
uqa24
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
bfvkxf3xwzkcgs z8s
17 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
12:35pm
6-K
EX-99.1
rqqndohnxrkcbg
2 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
2:03pm
6-K
EX-99.1
v0xw5eudl8ve58q
17 May 22
Replicel Life Sciences Inc. Provides Default Status Update
6:51pm
6-K
EX-99.1
ey1 s8v5q
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm